Literature DB >> 29417920

Emergency Airway Management in a Simulation of Highly Contagious Isolated Patients: Both Isolation Strategy and Device Type Matter.

Eike Plazikowski1, Robert Greif1, Jonas Marschall2, Tina H Pedersen1, Maren Kleine-Brueggeney1, Roland Albrecht3, Lorenz Theiler1.   

Abstract

OBJECTIVE To compare 6 airway-management devices in 3 isolation scenarios regarding their effect on airway management: portable isolation unit (PIU), personal protective equipment (PPE), and standard protection measures METHODS In total, 30 anesthesiologists working in emergency medical services performed airway management on mannequins in 3 isolation settings using 6 different airway management devices (in random order): (1) standard Macintosh laryngoscope; (2) Airtraq SP-video-laryngoscope; (3) i-gel; (4) LMA-Fastrach; (5) Ambu fiberoptic-aScope; and (6) Melker cricothyrotomy-set. Each was assessed regarding time-to-ventilate (primary outcome) and rating of difficulty handling the device. RESULTS In 86% (standard protection) and 85% (PPE) of attempts, airway management was achieved in <60 seconds, irrespective of the device used. In the PIU setting, only 69% of attempts succeeded within this time frame (P<.05). Median time-to-ventilate was shorter for standard protection (23 seconds) and PPE (25 seconds) compared to the PIU (38 seconds; P<.001). In the PIU setting, the fiberscope took the longest (median, 170 seconds), while i-gel was the quickest (median, 13 seconds). The rating of difficulty (visual analogue scale [VAS], 0-100) differed significantly between the isolation scenarios: Airway management was most difficult with PIU (VAS, 76), followed by PPE (VAS, 35), and standard protection (VAS, 9) (P<.01). CONCLUSION Wearing PPE produced similar times-to-ventilate as standard protection among anesthesiologists, but it was subjectively rated more difficult. The portable isolation unit permitted acceptable times-to-ventilate when excluding fiberscope and cricothyrotomy. Supraglottic airway devices allowed the fastest airway management in all isolation scenarios, thus being highly recommendable if a portable isolation unit is used and emergency airway management becomes necessary. Infect Control Hosp Epidemiol 2018;39:145-151.

Entities:  

Mesh:

Year:  2018        PMID: 29417920     DOI: 10.1017/ice.2017.287

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  A Multidisciplinary Intubation Algorithm for Suspected COVID-19 Patients in the Emergency Department.

Authors:  Lauren L Trembley; Adam Z Tobias; Gwendolyn Schillo; Nicholas von Foerster; Jordan Singer; Samantha L Pavelka; Paul Phrampus
Journal:  West J Emerg Med       Date:  2020-06-03

2.  Systematic review of simulated airway management whilst wearing personal protective equipment.

Authors:  Filippo Sanfilippo; Stefano Tigano; Gaetano J Palumbo; Marinella Astuto; Paolo Murabito
Journal:  Br J Anaesth       Date:  2020-06-13       Impact factor: 9.166

3.  Long-Distance Aeromedical Transport of Patients with COVID-19 in Fixed-Wing Air Ambulance Using a Portable Isolation Unit: Opportunities, Limitations and Mitigation Strategies.

Authors:  Dirk Schwabe; Bernhard Kellner; Dirk Henkel; Heinz Jürgen Pilligrath; Stefanie Krummer; Sascha Zach; Cornelia Rohrbeck; Michael Diefenbach; Alex Veldman
Journal:  Open Access Emerg Med       Date:  2020-11-24

4.  Helicopter transport of critical care COVID-19 patients in the Netherlands: protection against COVID-19 exposure-a challenge to critical care retrieval personnel in a novel operation.

Authors:  Ed J Spoelder; Marijn C T Tacken; Geert-Jan van Geffen; Cor Slagt
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-02-26       Impact factor: 2.953

Review 5.  Transport of COVID-19 and other highly contagious patients by helicopter and fixed-wing air ambulance: a narrative review and experience of the Swiss air rescue Rega.

Authors:  Roland Albrecht; Jürgen Knapp; Lorenz Theiler; Marcus Eder; Urs Pietsch
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-05-14       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.